The low expression of fc-gamma receptor iii (cd16) and high expression of fc-gamma receptor i (cd64) on neutrophil granulocytes mark severe covid-19 pneumonia

HIGHLIGHTS

  • who: Joerg Hoffmann and colleagues from the Department of Hematology, Oncology and Immunology, University Hospital Giessen and Marburg, Philipps University Marburg, Baldingerstrasse, Marburg, Germany have published the research: The Low Expression of Fc-Gamma Receptor III (CD16) and High Expression of Fc-Gamma Receptor I (CD64) on Neutrophil Granulocytes Mark Severe COVID-19 Pneumonia, in the Journal: Diagnostics 2022, 12, x FOR PEER REVIEW Procalcitonin, of /2022/
  • what: The aim of this study was to identify characteristics in the immunophenotype of the neutrophil granulocytes and monocytes that are distinctive of a COVID-19 infection and . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?